Anika Therapeutics (ANIK)
NASDAQ:ANIK
Holding ANIK?
Track your performance easily

Anika Therapeutics (ANIK) Financial Statements

157 Followers

Anika Therapeutics Financial Overview

Anika Therapeutics's market cap is currently ―. The company's EPS TTM is $-6.64; its P/E ratio is -2.60; Anika Therapeutics is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 38.75M$ 41.92M$ 42.97M$ 41.47M$ 44.30M
Gross Profit$ 1.44M$ 27.36M$ 26.33M$ 24.94M$ 28.97M
EBIT$ -27.61M$ 756.00K$ -1.59M$ -7.04M$ -3.07M
EBITDA$ -24.84M$ 3.22M$ 1.98M$ -2.95M$ 1.02M
Net Income Common Stockholders$ -29.92M$ -88.00K$ -63.00M$ -6.58M$ -2.74M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 90.72M$ 96.59M$ 108.83M$ 105.33M$ 101.81M
Total Assets$ 231.41M$ 262.65M$ 270.63M$ 328.16M$ 328.88M
Total Debt$ 25.24M$ 25.79M$ 26.90M$ 27.25M$ 27.77M
Net Debt$ -65.48M$ -70.81M$ -81.92M$ -78.08M$ -74.03M
Total Liabilities$ 51.54M$ 52.32M$ 58.37M$ 57.67M$ 54.87M
Stockholders Equity$ 179.86M$ 210.34M$ 212.26M$ 270.49M$ 274.01M
Cash Flow-
Free Cash Flow$ 3.20M$ -4.47M$ 1.80M$ 5.74M$ -9.75M
Operating Cash Flow$ 5.02M$ -1.07M$ 3.64M$ 6.49M$ -8.29M
Investing Cash Flow$ -1.82M$ -3.40M$ -1.84M$ -741.00K$ -1.46M
Financing Cash Flow$ -3.99M$ -1.11M$ 342.00K$ -110.00K$ -4.94M
Currency in USD

Anika Therapeutics Earnings and Revenue History

Anika Therapeutics Debt to Assets

Anika Therapeutics Cash Flow

Anika Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis